Institution
Alfred Health
- 47running trials
- 22closed trials
- 14,960publications (OpenAlex)
Running trials
Recruiting
Recruiting
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Recruiting
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
Active, not recruiting
Enrolling by invitation
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Active, not recruiting
Active, not recruiting
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Recruiting
Recruiting
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
Active, not recruiting
Recruiting
Recruiting
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Active, not recruiting
Active, not recruiting
Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Recruiting
Recruiting
Active, not recruiting
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
Active, not recruiting
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy5 recruiting
- Melanoma3 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Lung cancer2 recruiting
- Alzheimer disease1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Brain metastases1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Mild cognitive impairment1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myotonic dystrophy1 recruiting
- Pancreatic cancer1 recruiting
- Parkinson disease1 recruiting
- Prostate cancer1 recruiting
- Stroke1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Terminated
Terminated
Completed
Secondary Access - FEmoral or Radial in Transcatheter Aortic Valve Implantation?
Completed
Completed
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Terminated
Completed
Completed
Completed
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Completed
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Completed
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
Completed
Terminated
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Recruiting
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Completed
Completed
Completed
A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
Completed
Completed
Completed
Completed
Registry name variants (8)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Alfred Health
Melbourne, Victoria 3004
61 trials
Alfred Health
Parkville, Victoria 3050
2 trials
Alfred Health
Melbourne, Victoria 3004
1 trial
Alfred Health, Medical Oncology Unit, Second floor William Buckland Radiotherapy Center
Melbourne, Victoria 3004
1 trial
NCT05727176Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Contact: Taiho Oncology, INC
Alfred Health (Site 0018)
Melbourne, Victoria 3004
1 trial
Alfred Health (Site 0230)
Melbourne, Victoria 3004
1 trial
Alfred Health (Site 0902)
Melbourne, Victoria 3004
1 trial
Victorian Melanoma Service, Alfred Health
Melbourne, Victoria 3004
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Epilepsy52 works · 9 trials
- Chronic lymphocytic leukaemia7 works · 4 trials
- Iron deficiency anaemia5 works · 0 trials
- Mantle cell lymphoma4 works · 2 trials
Institution data: ROR 04scfb908 (CC0-1.0)Updated 15 Nov 2026